Company intelligence / Profile preview

Ioptex Research

Azusa, California, USA

Ownership: Private
Development stage: Other

Overview

Ioptex Research was a pioneering medical device company focused on the ophthalmology market, specifically the development and production of intraocular lenses (IOLs) for cataract patients. Established in 1983 and headquartered in Azusa, California, the company played a significant role in the evolution of IOL technology during the 1980s. Ioptex was acquired by Smith & Nephew in 1987 for approximately $236 million, marking a major consolidation in the ophthalmic device industry. The Ioptex business unit was later sold by Smith & Nephew to Allergan in 1993. Today, its legacy technologies are part of the broader history of modern ophthalmic surgery.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Ioptex Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ioptex Research.

Explore the full profile